Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

SS-31 Oral Taste: Formulation Comparison

Different administration strategies for SS-31 produce dramatically different sensory profiles and bioavailability outcomes. This table compares the four most common approaches in research settings: Aqueous solution (unbuffered water) 8.5–9.5 25–40 minutes 100%

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Different administration strategies for SS-31 produce dramatically different sensory profiles and bioavailability outcomes. This table compares the four most common approaches in research settings:
  • Aqueous solution (unbuffered water)
  • 8.5–9.5
  • 25–40 minutes
  • 100% (baseline 2–5%)
  • Highest bioavailability but worst palatability. Use only when taste is not a compliance barrier
  • PBS pH 7.4 + immediate water rinse
  • 6.5–7.5
  • 8–15 minutes
  • 95–100%
  • Best balance of bioavailability and tolerability for most protocols. Our standard recommendation
  • Lipid emulsion (MCT oil-based)
  • 3.5–5.0
  • 5–10 minutes
  • 70–80%
  • Acceptable palatability but significant absorption penalty. Use only when compliance is critical
  • Enteric-coated capsule
  • 0–1.0
  • None (if intact)
  • 60–75%
  • Eliminates taste entirely but introduces manufacturing complexity and variable release. Rarely practical for research
  • Orange juice or acidic vehicle
  • 4.0–6.0
  • 10–20 minutes
  • 45–60%
  • Poor choice despite taste improvement. Acidic pH degrades peptide before absorption
  • AMP bitter blocker (50mg) in PBS
  • 4.5–6.0
  • 6–12 minutes
  • 90–95%
  • Effective taste reduction with minimal bioavailability impact. Good compromise when palatability matters
  • The comparison makes clear that no formulation eliminates SS-31 oral taste without trade-offs. Researchers must prioritize based on whether their protocol is single-dose (where tolerability matters less) or chronic administration (where compliance becomes limiting). The PBS rinse approach offers the most favorable risk-benefit ratio for multi-dose studies where both absorption efficiency and subject retention matter.